Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huoxin Pill for chronic stable angina
ChiCTR1900024296Phase 4Recruiting
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Aug 2018
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Huoxin Pill in angina pectoris and coronary arteriosclerosis (3 arms), sponsored by Shanghai Changzheng Hospital. Primary endpoint: TCM syndrome integral. Started Aug 2018; status: recruiting.
02
Drugs
Huoxin Pill
03
Conditions
angina pectoriscoronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR1900024296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024296.